Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 1/20 | 0.66 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.66 |
| ▸ | PI4KA | P42356 | 2/20 | 0.52 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.52 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.52 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | DRD3 | P35462 | 1/20 | 0.52 |
| ▸ | XDH | P47989 | 1/20 | 0.52 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.52 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.47 |
| ▸ | CDK2 | P24941 | 5/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.47 |
| ▸ | PNP | P00491 | 1/20 | 0.46 |
| ▸ | CDK1 | P06493 | 4/20 | 0.44 |
| ▸ | CCNB1 | P14635 | 4/20 | 0.44 |
| ▸ | CCNA2 | P20248 | 4/20 | 0.44 |
| ▸ | CCNA1 | P78396 | 4/20 | 0.44 |
| ▸ | POLA1 | P09884 | 2/20 | 0.43 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19780 | 1.00 | PDPK1 (0.66) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| Sulfuric Acid SCHEMBL30128586 | 0.90 | PDPK1 (0.54) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| Furan SCHEMBL28428662 | 0.88 | PDPK1 (0.53) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| Thioguanine SCHEMBL9153902 | 0.86 | PDPK1 (0.63) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| Triphosphate SCHEMBL30196670 | 0.82 | PDPK1 (0.46) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| 2,6-Diaminopurine SCHEMBL29143272 | 0.80 | PDPK1 (0.92) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| SCHEMBL542009 | 0.79 | PDPK1 (0.59) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| 2,6-Diaminopurine SCHEMBL24053 | 0.79 | PDPK1 (1.00) | PDPK1GDAPI4KAPI4K2BPI4K2A | |
| SCHEMBL20611894 | 0.79 | PDPK1 (0.44) | PDPK1GDAXDHLRRK2MAP3K5 | |
| SCHEMBL29366073 | 0.79 | PDPK1 (0.44) | PDPK1GDAXDHLRRK2MAP3K5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 612 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028668-A1 | DETECTION OF BASE MODIFICATIONS BY ENHANCING ELECTRICAL CONTRAST IN NANOPORES | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2026-01-29 | — | — | US | claimed |
| EP-4634380-A1 | INTERNAL RIBOSOME ENTRY SITES FOR IMPROVED POLYNUCLEOTIDE TRANSLATION | ModernaTX, Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| EP-4565717-A1 | DETECTION OF BASE MODIFICATIONS BY ENHANCING ELECTRICAL CONTRAST IN NANOPORES | Ramot at Tel-Aviv University Ltd. (IL) | 2025-06-11 | — | — | EP | claimed |
| EP-4565692-A2 | INTERNAL RIBOSOME ENTRY SITES FOR IMPROVED POLYNUCLEOTIDE TRANSLATION | ModernaTX, Inc. (US) | 2025-06-11 | — | — | EP | claimed |
| CN-120041540-A | Novel method for efficiently cutting solid-phase surface DNA chain and application thereof in sequencing | 深圳赛陆医疗科技有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-119876360-A | Linearization method for NGS sequencing, sequencing chip and sequencing method | 深圳赛陆医疗科技有限公司 | 2025-04-25 | — | — | CN | claimed |
| US-20250129308-A1 | SEMICONDUCTOR TREATMENT LIQUID, TREATMENT METHOD FOR OBJECT TO BE TREATED, AND MANUFACTURING METHOD OF ELECTRONIC DEVICE | FUJIFILM CORP (JP) | 2025-04-24 | — | — | US | claimed |
| WO-2025060642-A1 | MODIFIED NUCLEOTIDE COMPOUND, OLIGONUCLEOTIDE THEREOF, AND USE THEREOF | 广州必贝特医药股份有限公司 | 2025-03-27 | — | — | WO | claimed |
| CN-119685462-A | Linearization method for NGS sequencing, sequencing chip and sequencing method | 深圳赛陆医疗科技有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-118914565-A | N6Methyladenine (m)6A) Application of reading protein hnRNPA2B1 in diagnosis and treatment of disuse osteoporosis | 中国人民解放军空军军医大学 | 2024-11-08 | — | — | CN | claimed |
| CN-116790733-A | Deaminase-assisted N in RNA 6 Method for the localization analysis of methyladenine | 武汉大学 | 2023-09-22 | — | — | CN | claimed |
| CN-116763938-A | Extracellular vesicle nucleic acid nano-drug delivery system, preparation method and application thereof | 国家纳米科学中心 | 2023-09-19 | — | — | CN | claimed |
| US-20230212644-A1 | IMAGING AND SEQUENCING PROTEIN-DNA INTERACTIONS IN SINGLE CELLS USING INTEGRATED MICROFLUIDICS | CZ BIOHUB SF, LLC | 2023-07-06 | — | — | US | claimed |
| CN-115852494-A | Construction method of target sequencing library | 清华大学 | 2023-03-28 | — | — | CN | claimed |
| CN-115786453-A | Analysis method and kit for single base resolution positioning of N6-methyladenine in DNA assisted by deaminase | 深圳市小分子新药创新中心有限公司 | 2023-03-14 | — | — | CN | claimed |
| CN-115404350-A | Method for recovering gold by using nitrogen-containing basic group compound modified adsorption resin | 华中科技大学 | 2022-11-29 | — | — | CN | claimed |
| EP-4058152-A1 | OLIGONUCLEOTIDE INTERFERENCE TREATMENTS OF PROSTATE CANCER | The Board of Regents of the University of Oklahoma (US) | 2022-09-21 | — | — | EP | claimed |
| CN-114137053-B | Antibody enzyme-free assisted photoelectrochemical sensor for detecting m 6 Method A | 山东农业大学 | 2022-08-19 | — | — | CN | claimed |
| CN-114807328-A | Method for marking and identifying single-base resolution DNA | 浙江大学 | 2022-07-29 | — | — | CN | claimed |
| CN-114137053-A | Antibody enzyme-free assisted photoelectrochemical sensor for detecting m6Method A | 山东农业大学 | 2022-03-04 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028668-A1 | DETECTION OF BASE MODIFICATIONS BY ENHANCING ELECTRICAL CONTRAST IN NANOPORES | NCL, PCNA, DNMT1 | PDPK1 3593/4885GDA 247/4885PI4KA 4238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.